Glyceraldehyde-3-phosphate Dehydrogenase Common Peptides of
adjuvants
glyceraldehyde-3-phosphate-dehydrogenase
listeriosis
pneumonia
tuberculosis
vaccines
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
17 Mar 2021
17 Mar 2021
Historique:
received:
14
02
2021
revised:
10
03
2021
accepted:
12
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Universal vaccines can be prepared with antigens common to different pathogens. In this regard, the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a common virulence factor among pathogenic bacteria of the genera Listeria, Mycobacterium and Streptococcus. Their N-terminal 22 amino acid peptides, GAPDH-L1 (
Identifiants
pubmed: 33802959
pii: vaccines9030269
doi: 10.3390/vaccines9030269
pmc: PMC8002646
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Comisión Interministerial de Ciencia y Tecnología
ID : SAF2012-34203
Organisme : European Cooperation in Science and Technology
ID : ENOVA
Organisme : Instituto de Salud Carlos III
ID : PI19-01580
Organisme : Instituto de Salud Carlos III
ID : DTS-00022
Organisme : Instituto de Salud Carlos III
ID : CIB16-NM009
Organisme : Instituto de Investigación Marqués de Valdecilla
ID : INNVAL19/26
Organisme : Comunidad de Madrid
ID : S2017/BMD-3671. INFLAMUNE-CM
Organisme : Comisión Interministerial de Ciencia y Tecnología
ID : SAF2016-75988-R
Organisme : Instituto de Salud Carlos III
ID : BIOIMID
Références
Nanomaterials (Basel). 2016 Aug 19;6(8):
pubmed: 28335280
Vaccine. 2012 Mar 30;30(16):2633-9
pubmed: 22365841
J Immunol Methods. 2015 Sep;424:111-9
pubmed: 26031451
J Immunol. 2014 Aug 15;193(4):1560-6
pubmed: 25000981
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
Clin Infect Dis. 2017 Feb 15;64(4):501-509
pubmed: 28172588
Lancet. 2017 Dec 17;388(10063):3036-3047
pubmed: 27265346
Immunome Res. 2008 Jan 25;4:2
pubmed: 18221540
Oncotarget. 2017 Jul 20;8(33):53916-53934
pubmed: 28903312
Immunity. 2006 May;24(5):491-4
pubmed: 16713963
Int J Med Sci. 2021 Jan 1;18(2):406-418
pubmed: 33390810
Traffic. 2008 Mar;9(3):325-37
pubmed: 18088303
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):488-93
pubmed: 25548169
PLoS One. 2012;7(6):e39193
pubmed: 22723962
BMC Bioinformatics. 2005 May 31;6:132
pubmed: 15927070
Protein Sci. 2003 May;12(5):1007-17
pubmed: 12717023
Front Immunol. 2018 Dec 17;9:2936
pubmed: 30619296
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W509-12
pubmed: 18463140
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W525-30
pubmed: 22610854
Nucleic Acids Res. 2021 Jan 8;49(D1):D344-D354
pubmed: 33156333
Electrophoresis. 2009 Jun;30 Suppl 1:S162-73
pubmed: 19517507
J Biol Chem. 1999 Apr 23;274(17):11459-62
pubmed: 10206948
J Clin Microbiol. 2013 Nov;51(11):3591-6
pubmed: 23966491
Nucleic Acids Res. 2016 Jul 8;44(W1):W449-54
pubmed: 27131374
Clin Infect Dis. 2010 Jul 1;51(1):58-65
pubmed: 20491545
Front Cell Infect Microbiol. 2020 Oct 28;10:573348
pubmed: 33194812
Front Cell Infect Microbiol. 2014 Feb 21;4:22
pubmed: 24600592
Euro Surveill. 2019 May;24(21):
pubmed: 31138365
Pharmaceutics. 2020 Jul 11;12(7):
pubmed: 32664555
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Hum Vaccin Immunother. 2014;10(9):2664-73
pubmed: 25483666
Nucleic Acids Res. 2017 Jan 4;45(D1):D313-D319
pubmed: 27899672
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Nanomedicine. 2013 Oct;9(7):972-84
pubmed: 23506949
Infect Immun. 2001 Sep;69(9):5329-34
pubmed: 11500402
Infez Med. 2017 Sep 1;25(3):210-216
pubmed: 28956537
Dermatol Clin. 2015 Jul;33(3):563-77
pubmed: 26143432
Front Microbiol. 2020 Nov 24;11:559105
pubmed: 33343515
Immun Ageing. 2018 Jan 22;15:3
pubmed: 29387135